| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_accf6786c55a2017563c04793a540cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 |
| filingDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9bcb5fd8dda6dd8c6b435d083760bb |
| publicationDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006072596-A1 |
| titleOfInvention |
6- (2 , 3 , 4 , 5-TETRAHYDRO-lH-BENZO [D] AZEPIN-7-YLOXY) -NICOTAMIDE DERIVATIVES AS RADIOLABELLED LIGANDS |
| abstract |
The present invention relates to radiolabelled compounds of formula (I) which are useful for the labelling and diagnostic imaging of histamine H3 receptor functionality. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9108948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014047209-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8829041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2441014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103641796-A |
| priorityDate |
2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |